Multiple studies have shown that patient outcomes from stroke, myocardial infarction, and other events are worse at night, and hospitalists and administrators hope that putting more physicians on the floor will
In particular, heparin offered a significant advantage in avoiding acute stent thrombosis (RR, 3.26; 95% CI, 1.32 to 8.07; P=0.007) and associated new myocardial infarction or
In Canada, readmission rates and postdischarge mortality have declined among patients hospitalized with acute myocardial infarction or heart failure in recent years, a recent analysis found. ... When standardized for age and sex, overall hospitalization
Older patients who have a history of stable angina but no history of myocardial infarction (MI) or systolic heart failure may not benefit from beta-blocker use at discharge after elective
Transfusion at lower hemoglobin threshold appears as safe as higher threshold for septic shock patients
Patients with acute myocardial infarction were excluded from this trial, they warned, so research is still needed to assess the safety of lower hemoglobin thresholds for transfusion in this patient subgroup.
hemorrhagic or ischemic stroke, gastrointestinal bleeding, pulmonary embolism, deep venous thrombosis, and myocardial infarction.
deaths), nonfatal myocardial infarction or stent thrombosis. ... Researchers also could not assess the effectiveness of high-dose clopidogrel in reducing the incidence of periprocedural myocardial infarction.
9, 2008, to Jan. 21, 2015. Patients were eligible for the study if they had stable or unstable angina pectoris or non-ST-elevation myocardial infarction (MI).
Treatment with dual antiplatelet therapy (DAPT) appears to be safer than DAPT plus warfarin (triple therapy) in older patients with acute myocardial infarction (MI) and atrial fibrillation who underwent coronary stenting,
to benefit (history of myocardial infarction, cerebrovascular disease, or renal disease).